Rating History for Checkmate Pharmaceuticals (CMPI) by BofA Securities

More Stocks Rated by BofA Securities | Latest Ratings for CMPI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/31/2022 Geoff Meacham Maintain Buy
(N/A)		 6.00
(7.00)		  
 		   Details